Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

º¹°­³» ¹× Èĺ¹¸·°­ À°Á¾ Intraperitoneal and Retroperitoneal Sarcomas

´ëÇѾÏÇÐȸÁö 1999³â 31±Ç 1È£ p.173 ~ 179
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤¿µ¿í/Young Wook Jung ³ë¿ìö/¹®³­¸ð/¹é³²¼±/ÀÌÁ¾ÀÎ/ÃÖµ¿¿í/¹æÈ£À±/Woo Cheol Noh/Nan Mo Moon/Nam Sun Park/Jong Inn Lee/Dong Wook Choi/Ho Yoon Bang

Abstract

¼­·Ð
¿¬ºÎÁ¶Á÷ À°Á¾ÀÇ ºóµµ´Â ¸ðµç ¾Ç¼º Á¾¾çÀÇ 1%ÀÌÇÏÀ̸ç ƯÈ÷ º¹°­³» ¹× Èĺ¹¸·°­ À°Á¾Àº
°¢°¢ Àüü À°Á¾ÀÇ 4%, 15% Á¤µµ¸¦ Â÷ÁöÇÏ´Â ºñ±³Àû µå¹® Á¾¾çÁßÀÇ ÇϳªÀÌ´Ù. ´ëºÎºÐÀÇ º¹
°­³» ¹× Èĺ¹¸·°­ À°Á¾Àº Áõ»óÀÌ ºñƯÀÌÀûÀ̸ç Á¾¾çÀÌ Ä¿ÁøÈÄ¿¡ ¹ß°ßµÇ°í Áø´Ü ´ç½Ã ¿ø°Ý
ÀüÀÌ°¡ ÀÖ´Â °æ¿ì°¡ ¸¹´Ù. º¹°­³» ¹× Èĺ¹¸·°­ À°Á¾ÀÇ Ä¡·á´Â ¿Ü°úÀûÀÎ ÀýÁ¦°¡ °¡Àå Áß¿äÇÏ
¸ç º¸Á¶¿ä¹ýÀ¸·Î ½ÃÇàÇÏ´Â È­Çпä¹ý°ú ¹æ»ç¼± Ä¡·áÀÇ È¿°ú´Â ¾ÆÁ÷ ÀÔÁõµÇ¾î ÀÖÁö ¸øÇÑ ½ÇÁ¤
ÀÌ´Ù.
ÀúÀÚµéÀº º¹°­³» ¹× Èĺ¹¸·°­ À°Á¾ÀÇ ÀÓ»ó º´¸®ÇÐÀû ºÐ¼®°ú Àç¹ß¿¡ ¿µÇâÀ» ÁÖ´Â ÀÎÀÚ¸¦
ã¾Æ³»¾î ÇâÈÄ À̵é Á¾¾çÀÇ Ä¡·á ¹æħÀ» ¼¼¿ì´Âµ¥ µµ¿òÀÌ µÇ°íÀÚ ÇÏ¿´´Ù.

Purpose: Sarcomas arising in intraperitoneal cavity and retroperitoneal space are
relatively uncommon. Thus, studies characterizing the results of long-term follow-up are
limited. The purpose of this study was to identify the clinicopathologic features and
prognostic factors of intraperitoneal and retroperitoneal sarcomas.
Materials and Method: Thirtyeight patients with intraperitoneal or retroperitoneal
sarcoma who had been treated at Department of Surgery, Korea Cancer Center Hospital
during the period from January 1987 to December 1997 were reviewed retrospectively.
Results: The ratio between male to female was 0.9 : 1. The mean age of the patients
was 48.3 (32¡­75) years. The most common symptom was abdominal pain or discomfort
(61%), followed by palpable mass (55%), GI bleeding (34%), weight loss (26%), and
change of bowel habits (21%). The most common histologic type was leiomyosarcoma
(73.7%), followed by liposarcoma (23.7%), and malignant fibrous histiocytoma (2.6%).
The mean tumor size was 15.5¡¿12.1¡¿8.7 §¯. Among 38 cases, 25 cases developed in
intraperitoneal cavity and 13 cases arose in retroperitoneal space. Overall, 44 operations
were performed in 31 patients. Among them, complete surgical resection constituted
73%. In 20 cases, combined resection of adjacent organ was performed to accomplish
complete surgical resection of tumors. During the median follow up period of 23 months
(3¡­116 months), the overall 5-year survival rate was 34.7%. The patients who had been
treated by complete surgical resection showed better survival than those in whom
palliative resection or biopsy only was performed (38.6% vs 0% of 5 YSR, p=0.015).
Liposarcoma showed better prognosis than leiomyosarcoma (41.7% vs 34.2% of 5 YSR,
p=0.0000). The size of tumor (10 §¯>vs 10 §¯¡Â) was not a statistically significant
prognostic factor.
Conclusion: In this series, The histologic type and complete surgical resection were
important factors that can affect the survival of the patients. Aggressive surgical
resections are therefore warranted to obtain better outcome of the patients with
intraperitoneal and retroperitoneal sarcomas.

Å°¿öµå

Sarcoma; Intraperitoneal; Retroperitoneal;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS